{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:37:37Z","timestamp":1776440257285,"version":"3.51.2"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12311-021-01262-7","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T17:15:58Z","timestamp":1622135758000},"page":"86-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor\/Ataxia Syndrome"],"prefix":"10.1007","volume":"21","author":[{"given":"Diana A.","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thu T. A.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah A.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Robertson-Dick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Berry-Kravis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie M.","family":"Cologna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"issue":"4","key":"1262_CR1","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ncl.2013.04.008","volume":"31","author":"DA Hall","year":"2013","unstructured":"Hall DA, O\u2019Keefe JA. Clinical neurogenetics: fragile x-associated tremor\/ataxia syndrome. Neurol Clin. 2013;31(4):1073\u201384.","journal-title":"Neurol Clin"},{"issue":"5","key":"1262_CR2","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s12311-016-0799-4","volume":"15","author":"DA Hall","year":"2016","unstructured":"Hall DA, Robertson E, Shelton AL, Losh MC, Mila M, Moreno EG, et al. Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers. Cerebellum. 2016;15(5):578\u201386.","journal-title":"Cerebellum"},{"issue":"Pt A","key":"1262_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainres.2018.02.006","volume":"1693","author":"MR Glineburg","year":"2018","unstructured":"Glineburg MR, Todd PK, Charlet-Berguerand N, Sellier C. Repeat-associated non-AUG (RAN) translation and other molecular mechanisms in Fragile X Tremor Ataxia Syndrome. Brain Res. 2018;1693(Pt A):43\u201354.","journal-title":"Brain Res"},{"key":"1262_CR4","doi-asserted-by":"publisher","first-page":"104740","DOI":"10.1016\/j.nbd.2020.104740","volume":"136","author":"MJ Salcedo-Arellano","year":"2020","unstructured":"Salcedo-Arellano MJ, Dufour B, McLennan Y, Martinez-Cerdeno V, Hagerman R. Fragile X syndrome and associated disorders: Clinical aspects and pathology. Neurobiol Dis. 2020;136:104740.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1262_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1866-1955-6-23","volume":"6","author":"C Sellier","year":"2014","unstructured":"Sellier C, Usdin K, Pastori C, Peschansky VJ, Tassone F, Charlet-Berguerand N. The multiple molecular facets of fragile X-associated tremor\/ataxia syndrome. J Neurodev Disord. 2014;6(1):23.","journal-title":"J Neurodev Disord"},{"issue":"5","key":"1262_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s12311-016-0800-2","volume":"15","author":"T Botta-Orfila","year":"2016","unstructured":"Botta-Orfila T, Tartaglia GG, Michalon A. Molecular Pathophysiology of Fragile X-Associated Tremor\/Ataxia Syndrome and Perspectives for Drug Development. Cerebellum. 2016;15(5):599\u2013610.","journal-title":"Cerebellum"},{"key":"1262_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fncel.2017.00128","volume":"11","author":"HE Kong","year":"2017","unstructured":"Kong HE, Zhao J, Xu S, Jin P, Jin Y. Fragile X-Associated Tremor\/Ataxia Syndrome: From Molecular Pathogenesis to Development of Therapeutics. Front Cell Neurosci. 2017;11:128.","journal-title":"Front Cell Neurosci"},{"key":"1262_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fgene.2018.00100","volume":"9","author":"DA Hall","year":"2018","unstructured":"Hall DA, Hagerman RJ. Fragile X-Associated Tremor\/Ataxia Syndrome: Unmet Needs and a Path for the Future. Front Genet. 2018;9:100.","journal-title":"Front Genet"},{"issue":"2","key":"1262_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/mdc3.12708","volume":"6","author":"DA Hall","year":"2019","unstructured":"Hall DA, Stebbins GT, Jacquemont S, Berry-Kravis E, Goetz CG, Hagerman R, et al. Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale. Mov Disord Clin Pract. 2019;6(2):120\u20134.","journal-title":"Mov Disord Clin Pract"},{"issue":"12","key":"1262_CR10","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1021\/acs.jproteome.8b00300","volume":"17","author":"C Macron","year":"2018","unstructured":"Macron C, Lane L, Nunez Galindo A, Dayon L. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification. J Proteome Res. 2018;17(12):4113\u201326.","journal-title":"J Proteome Res"},{"issue":"10","key":"1262_CR11","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1021\/acs.jproteome.8b00308","volume":"17","author":"K Barkovits","year":"2018","unstructured":"Barkovits K, Linden A, Galozzi S, Schilde L, Pacharra S, Mollenhauer B, et al. Characterization of Cerebrospinal Fluid via Data-Independent Acquisition Mass Spectrometry. J Proteome Res. 2018;17(10):3418\u201330.","journal-title":"J Proteome Res"},{"issue":"5","key":"1262_CR12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1074\/mcp.M116.065524","volume":"16","author":"DL Plubell","year":"2017","unstructured":"Plubell DL, Wilmarth PA, Zhao Y, Fenton AM, Minnier J, Reddy AP, et al. Extended Multiplexing of Tandem Mass Tags (TMT) Labeling Reveals Age and High Fat Diet Specific Proteome Changes in Mouse Epididymal Adipose Tissue. Mol Cell Proteomics. 2017;16(5):873\u201390.","journal-title":"Mol Cell Proteomics"},{"issue":"9","key":"1262_CR13","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1021\/pr4005234","volume":"12","author":"XS Yue","year":"2013","unstructured":"Yue XS, Hummon AB. Combination of multistep IMAC enrichment with high-pH reverse phase separation for in-depth phosphoproteomic profiling. J Proteome Res. 2013;12(9):4176\u201386.","journal-title":"J Proteome Res"},{"issue":"10","key":"1262_CR14","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/pmic.201000722","volume":"11","author":"Y Wang","year":"2011","unstructured":"Wang Y, Yang F, Gritsenko MA, Wang Y, Clauss T, Liu T, et al. Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells. Proteomics. 2011;11(10):2019\u201326.","journal-title":"Proteomics"},{"issue":"6","key":"1262_CR15","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1021\/pr201068b","volume":"11","author":"Z Cao","year":"2012","unstructured":"Cao Z, Tang HY, Wang H, Liu Q, Speicher DW. Systematic comparison of fractionation methods for in-depth analysis of plasma proteomes. J Proteome Res. 2012;11(6):3090\u2013100.","journal-title":"J Proteome Res"},{"issue":"8","key":"1262_CR16","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s13361-019-02223-5","volume":"30","author":"TTA Nguyen","year":"2019","unstructured":"Nguyen TTA, Li W, Park TJ, Gong LW, Cologna SM. Investigating Phosphorylation Patterns of the Ion Channel TRPM7 Using Multiple Extraction and Enrichment Techniques Reveals New Phosphosites. J Am Soc Mass Spectrom. 2019;30(8):1359\u201367.","journal-title":"J Am Soc Mass Spectrom"},{"issue":"20","key":"1262_CR17","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1021\/ac025747h","volume":"74","author":"A Keller","year":"2002","unstructured":"Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search. Anal Chem. 2002;74(20):5383\u201392.","journal-title":"Anal Chem"},{"issue":"17","key":"1262_CR18","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1021\/ac0341261","volume":"75","author":"AI Nesvizhskii","year":"2003","unstructured":"Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem. 2003;75(17):4646\u201358.","journal-title":"Anal Chem"},{"key":"1262_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nbd.2013.12.020","volume":"65","author":"E Mateu-Huertas","year":"2014","unstructured":"Mateu-Huertas E, Rodriguez-Revenga L, Alvarez-Mora MI, Madrigal I, Willemsen R, Mil\u00e0 M, et al. Blood expression profiles of fragile X premutation carriers identify candidate genes involved in neurodegenerative and infertility phenotypes. Neurobiol Dis. 2014;65:43\u201354.","journal-title":"Neurobiol Dis"},{"key":"1262_CR20","doi-asserted-by":"publisher","unstructured":"Santos NBD, Franco RD, Camarini R, Munhoz CD, Eichler RAS, Gewehr MCF, Reckziegel P, Llanos RP, Dale CS, Silva V, et al. Thimet Oligopeptidase (EC 3.4.24.15) Key functions suggested by knockout mice phenotype characterization. Biomolecules. 2019;9:382. https:\/\/doi.org\/10.3390\/biom9080382.","DOI":"10.3390\/biom9080382"},{"issue":"1","key":"1262_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1750-1326-6-27","volume":"6","author":"H Zheng","year":"2011","unstructured":"Zheng H, Koo EH. Biology and pathophysiology of the amyloid precursor protein. Mol Neurodegener. 2011;6(1):27.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1262_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nbd.2010.08.016","volume":"41","author":"J Takahashi-Fujigasaki","year":"2011","unstructured":"Takahashi-Fujigasaki J, Breidert T, Fujigasaki H, Duyckaerts C, Camonis JH, Brice A, et al. Amyloid precursor-like protein 2 cleavage contributes to neuronal intranuclear inclusions and cytotoxicity in spinocerebellar ataxia-7 (SCA7). Neurobiol Dis. 2011;41(1):33\u201342.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1262_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/mas.20221","volume":"29","author":"H Hwang","year":"2010","unstructured":"Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, et al. Glycoproteomics in neurodegenerative diseases. Mass Spectrom Rev. 2010;29(1):79\u2013125.","journal-title":"Mass Spectrom Rev"},{"issue":"2","key":"1262_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4103\/1673-5374.244776","volume":"14","author":"M Chatterjee","year":"2019","unstructured":"Chatterjee M, Schild D, Teunissen CE. Contactins in the central nervous system: role in health and disease. Neural Regen Res. 2019;14(2):206\u201316.","journal-title":"Neural Regen Res"},{"issue":"2","key":"1262_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neuron.2018.11.032","volume":"101","author":"N Elazar","year":"2019","unstructured":"Elazar N, Vainshtein A, Golan N, Vijayaragavan B, Schaeren-Wiemers N, Eshed-Eisenbach Y, et al. Axoglial Adhesion by Cadm4 Regulates CNS Myelination. Neuron. 2019;101(2):224-31.e5.","journal-title":"Neuron"},{"issue":"7","key":"1262_CR26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nn1915","volume":"10","author":"I Spiegel","year":"2007","unstructured":"Spiegel I, Adamsky K, Eshed Y, Milo R, Sabanay H, Sarig-Nadir O, et al. A central role for Necl4 (SynCAM4) in Schwann cell-axon interaction and myelination. Nat Neurosci. 2007;10(7):861\u20139.","journal-title":"Nat Neurosci"},{"issue":"1","key":"1262_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1477-5956-12-5","volume":"12","author":"F Song","year":"2014","unstructured":"Song F, Poljak A, Kochan NA, Raftery M, Brodaty H, Smythe GA, et al. Plasma protein profiling of Mild Cognitive Impairment and Alzheimer\u2019s disease using iTRAQ quantitative proteomics. Proteome Sci. 2014;12(1):5.","journal-title":"Proteome Sci"},{"issue":"2","key":"1262_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3233\/JAD-180855","volume":"67","author":"PE Khoonsari","year":"2019","unstructured":"Khoonsari PE, Shevchenko G, Herman S, Remnestal J, Giedraitis V, Brundin R, et al. Improved Differential Diagnosis of Alzheimer\u2019s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers. J Alzheimers Dis. 2019;67(2):639\u201351.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"1262_CR29","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1021\/pr0700753","volume":"6","author":"A Dalrymple","year":"2007","unstructured":"Dalrymple A, Wild EJ, Joubert R, Sathasivam K, Bjorkqvist M, Petersen A, et al. Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res. 2007;6(7):2833\u201340.","journal-title":"J Proteome Res"},{"issue":"1","key":"1262_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/archneurol.2011.642","volume":"69","author":"JM Ringman","year":"2012","unstructured":"Ringman JM, Schulman H, Becker C, Jones T, Bai Y, Immermann F, et al. Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations. Arch Neurol. 2012;69(1):96\u2013104.","journal-title":"Arch Neurol"},{"issue":"3\u20134","key":"1262_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s12031-017-0942-9","volume":"62","author":"FN Emamzadeh","year":"2017","unstructured":"Emamzadeh FN. Role of Apolipoproteins and alpha-Synuclein in Parkinson\u2019s Disease. J Mol Neurosci. 2017;62(3\u20134):344\u201355.","journal-title":"J Mol Neurosci"},{"issue":"12","key":"1262_CR32","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1021\/bi002186k","volume":"40","author":"RP Koldamova","year":"2001","unstructured":"Koldamova RP, Lefterov IM, Lefterova MI, Lazo JS. Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity. Biochemistry. 2001;40(12):3553\u201360.","journal-title":"Biochemistry"},{"issue":"5","key":"1262_CR33","first-page":"350","volume":"122","author":"ES Wang","year":"2010","unstructured":"Wang ES, Sun Y, Guo JG, Gao X, Hu JW, Zhou L, et al. Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson\u2019s disease. Acta Neurol Scand. 2010;122(5):350\u20139.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"1262_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/ana.23872","volume":"74","author":"JK Qiang","year":"2013","unstructured":"Qiang JK, Wong YC, Siderowf A, Hurtig HI, Xie SX, Lee VM, et al. Plasma apolipoprotein A1 as a biomarker for Parkinson disease. Ann Neurol. 2013;74(1):119\u201327.","journal-title":"Ann Neurol"},{"issue":"3","key":"1262_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3892\/ijmm.2013.1250","volume":"31","author":"YS Kim","year":"2013","unstructured":"Kim YS, Gu BH, Choi BC, Kim MS, Song S, Yun JH, et al. Apolipoprotein A-IV as a novel gene associated with polycystic ovary syndrome. Int J Mol Med. 2013;31(3):707\u201316.","journal-title":"Int J Mol Med"},{"issue":"16","key":"1262_CR36","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.jacc.2017.08.053","volume":"70","author":"Y Dai","year":"2017","unstructured":"Dai Y, Shen Y, Li QR, Ding FH, Wang XQ, Liu HJ, et al. Glycated Apolipoprotein A-IV Induces Atherogenesis in Patients With CAD in Type 2 Diabetes. J Am Coll Cardiol. 2017;70(16):2006\u201319.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1262_CR37","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.kint.2016.04.003","volume":"90","author":"S Dasari","year":"2016","unstructured":"Dasari S, Amin MS, Kurtin PJ, Vrana JA, Theis JD, Grogg KL, et al. Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis. Kidney Int. 2016;90(3):658\u201364.","journal-title":"Kidney Int"},{"issue":"2","key":"1262_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","volume":"122","author":"H Reiber","year":"1994","unstructured":"Reiber H. Flow rate of cerebrospinal fluid (CSF)\u2013a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci. 1994;122(2):189\u2013203.","journal-title":"J Neurol Sci"},{"issue":"6","key":"1262_CR39","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1590\/0004-282x20160066","volume":"74","author":"H Reiber","year":"2016","unstructured":"Reiber H. Knowledge-base for interpretation of cerebrospinal fluid data patterns. Essentials in neurology and psychiatry. Arq Neuropsiquiatr. 2016;74(6):501\u201312.","journal-title":"Arq Neuropsiquiatr."},{"issue":"2","key":"1262_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","volume":"184","author":"H Reiber","year":"2001","unstructured":"Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001;184(2):101\u201322.","journal-title":"J Neurol Sci"},{"key":"1262_CR41","unstructured":"Werner A, inventorAlbaum IT-Solutions CSF Research Tool Ribergrams. M\u00f6hnesee, Germany patent DE282607638."},{"issue":"1","key":"1262_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s40478-019-0796-1","volume":"7","author":"L Ma","year":"2019","unstructured":"Ma L, Herren AW, Espinal G, Randol J, McLaughlin B, Martinez-Cerdeno V, et al. Composition of the Intranuclear Inclusions of Fragile X-associated Tremor\/Ataxia Syndrome. Acta Neuropathol Commun. 2019;7(1):143.","journal-title":"Acta Neuropathol Commun"},{"key":"1262_CR43","doi-asserted-by":"publisher","unstructured":"Marinello M, Werner A, Giannone M, Tahiri K, Alves S, Tesson C, den Dunnen W, Seeler J-S, Brice A, Sittler A. SUMOylation by SUMO2 is implicated in the degradation of misfolded ataxin-7 via RNF4 in SCA7 models. Dis Models Mech. 2019;12. https:\/\/doi.org\/10.1242\/dmm.036145.","DOI":"10.1242\/dmm.036145"},{"issue":"16","key":"1262_CR44","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.4161\/15384101.2014.943112","volume":"13","author":"RK Hukema","year":"2014","unstructured":"Hukema RK, Buijsen RA, Raske C, Severijnen LA, Nieuwenhuizen-Bakker I, Minneboo M, et al. Induced expression of expanded CGG RNA causes mitochondrial dysfunction in vivo. Cell Cycle. 2014;13(16):2600\u20138.","journal-title":"Cell Cycle"},{"issue":"5","key":"1262_CR45","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1590\/S0004-282X2010000500023","volume":"68","author":"LP Capelli","year":"2010","unstructured":"Capelli LP, Goncalves MR, Leite CC, Barbosa ER, Nitrini R, Vianna-Morgante AM. The fragile x-associated tremor and ataxia syndrome (FXTAS). Arq Neuropsiquiatr. 2010;68(5):791\u20138.","journal-title":"Arq Neuropsiquiatr"},{"key":"1262_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.mcn.2016.11.006","volume":"81","author":"G Gennarini","year":"2017","unstructured":"Gennarini G, Bizzoca A, Picocci S, Puzzo D, Corsi P, Furley AJW. The role of Gpi-anchored axonal glycoproteins in neural development and neurological disorders. Mol Cell Neurosci. 2017;81:49\u201363.","journal-title":"Mol Cell Neurosci"},{"issue":"Pt 6","key":"1262_CR47","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/brain\/aww062","volume":"139","author":"C Manso","year":"2016","unstructured":"Manso C, Querol L, Mekaouche M, Illa I, Devaux JJ. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects. Brain. 2016;139(Pt 6):1700\u201312.","journal-title":"Brain"},{"issue":"9","key":"1262_CR48","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/NEN.0b013e3181ed7a41","volume":"69","author":"B Zucker","year":"2010","unstructured":"Zucker B, Kama JA, Kuhn A, Thu D, Orlando LR, Dunah AW, et al. Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington disease. J Neuropathol Exp Neurol. 2010;69(9):880\u201395.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"1262_CR49","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1016\/S0022-2275(20)33324-1","volume":"39","author":"KS Montine","year":"1998","unstructured":"Montine KS, Bassett CN, Ou JJ, Markesbery WR, Swift LL, Montine TJ. Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins. J Lipid Res. 1998;39(12):2443\u201351.","journal-title":"J Lipid Res"},{"issue":"41","key":"1262_CR50","doi-asserted-by":"publisher","first-page":"12451","DOI":"10.1021\/bi00207a011","volume":"33","author":"CY Yang","year":"1994","unstructured":"Yang CY, Gu ZW, Blanco-Vaca F, Gaskell SJ, Yang M, Massey JB, et al. Structure of human apolipoprotein D: locations of the intermolecular and intramolecular disulfide links. Biochemistry. 1994;33(41):12451\u20135.","journal-title":"Biochemistry"},{"issue":"42","key":"1262_CR51","doi-asserted-by":"publisher","first-page":"31068","DOI":"10.1074\/jbc.M703552200","volume":"282","author":"A Eichinger","year":"2007","unstructured":"Eichinger A, Nasreen A, Kim HJ, Skerra A. Structural insight into the dual ligand specificity and mode of high density lipoprotein association of apolipoprotein D. J Biol Chem. 2007;282(42):31068\u201375.","journal-title":"J Biol Chem"},{"issue":"17","key":"1262_CR52","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1016\/S0021-9258(17)34612-4","volume":"253","author":"KH Weisgraber","year":"1978","unstructured":"Weisgraber KH, Mahley RW. Apoprotein (E\u2013A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J Biol Chem. 1978;253(17):6281\u20138.","journal-title":"J Biol Chem."},{"issue":"3","key":"1262_CR53","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/pr.58.3.1","volume":"58","author":"A Kontush","year":"2006","unstructured":"Kontush A, Chapman MJ. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev. 2006;58(3):342\u201374.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1262_CR54","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1038\/s41598-018-23755-y","volume":"8","author":"M Yang","year":"2018","unstructured":"Yang M, Liu Y, Dai J, Li L, Ding X, Xu Z, et al. Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure. Sci Rep. 2018;8(1):5620.","journal-title":"Sci Rep"},{"issue":"sup1","key":"1262_CR55","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/13506129.2017.1295949","volume":"24","author":"M Yang","year":"2017","unstructured":"Yang M, Liu Y, Li L, Miyahara H, Ding X, Dai J, et al. Apolipoprotein A-II accelerates reactive AA amyloidosis. Amyloid. 2017;24(sup1):147\u20138.","journal-title":"Amyloid"},{"key":"1262_CR56","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.2147\/DDDT.S89279","volume":"9","author":"Q Lin","year":"2015","unstructured":"Lin Q, Cao Y, Gao J. Decreased expression of the APOA1-APOC3-APOA4 gene cluster is associated with risk of Alzheimer\u2019s disease. Drug Des Devel Ther. 2015;9:5421\u201331.","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"1262_CR57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/0005-2760(94)00232-N","volume":"1255","author":"I Borghini","year":"1995","unstructured":"Borghini I, Barja F, Pometta D, James RW. Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim Biophys Acta. 1995;1255(2):192\u2013200.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"1262_CR58","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0022-2275(20)31605-9","volume":"42","author":"S Koch","year":"2001","unstructured":"Koch S, Donarski N, Goetze K, Kreckel M, Stuerenburg HJ, Buhmann C, et al. Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res. 2001;42(7):1143\u201351.","journal-title":"J Lipid Res"},{"key":"1262_CR59","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3389\/fneur.2019.01152","volume":"10","author":"M Corraliza-Gomez","year":"2019","unstructured":"Corraliza-Gomez M, Sanchez D, Ganfornina MD. Lipid-Binding Proteins in Brain Health and Disease. Front Neurol. 2019;10:1152.","journal-title":"Front Neurol"},{"issue":"7","key":"1262_CR60","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.neurobiolaging.2014.01.148","volume":"35","author":"S Dassati","year":"2014","unstructured":"Dassati S, Waldner A, Schweigreiter R. Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. Neurobiol Aging. 2014;35(7):1632\u201342.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"1262_CR61","doi-asserted-by":"publisher","first-page":"e3329","DOI":"10.1371\/journal.pone.0003329","volume":"3","author":"PM Loerch","year":"2008","unstructured":"Loerch PM, Lu T, Dakin KA, Vann JM, Isaacs A, Geula C, et al. Evolution of the aging brain transcriptome and synaptic regulation. PLoS ONE. 2008;3(10):e3329.","journal-title":"PLoS ONE"},{"issue":"2","key":"1262_CR62","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.nbd.2005.04.012","volume":"20","author":"PP Desai","year":"2005","unstructured":"Desai PP, Ikonomovic MD, Abrahamson EE, Hamilton RL, Isanski BA, Hope CE, et al. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer\u2019s disease temporal cortex. Neurobiol Dis. 2005;20(2):574\u201382.","journal-title":"Neurobiol Dis"},{"key":"1262_CR63","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.brainres.2008.07.018","volume":"1233","author":"Y Chen","year":"2008","unstructured":"Chen Y, Jia L, Wei C, Wang F, Lv H, Jia J. Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer\u2019s disease. Brain Res. 2008;1233:196\u2013202.","journal-title":"Brain Res"},{"issue":"11","key":"1262_CR64","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00702-013-1036-7","volume":"120","author":"N Shibata","year":"2013","unstructured":"Shibata N, Nagata T, Shinagawa S, Ohnuma T, Shimazaki H, Komatsu M, et al. Genetic association between APOA1 and APOD polymorphisms and Alzheimer\u2019s disease in a Japanese population. J Neural Transm (Vienna). 2013;120(11):1599\u2013603.","journal-title":"J Neural Transm (Vienna)"},{"issue":"8","key":"1262_CR65","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00415-004-0470-8","volume":"251","author":"S Helisalmi","year":"2004","unstructured":"Helisalmi S, Hiltunen M, Vepsalainen S, Iivonen S, Corder EH, Lehtovirta M, et al. Genetic variation in apolipoprotein D and Alzheimer\u2019s disease. J Neurol. 2004;251(8):951\u20137.","journal-title":"J Neurol"},{"key":"1262_CR66","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2017.10.025","volume":"267","author":"A Wolska","year":"2017","unstructured":"Wolska A, Dunbar RL, Freeman LA, Ueda M, Amar MJ, Sviridov DO, et al. Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism. Atherosclerosis. 2017;267:49\u201360.","journal-title":"Atherosclerosis"},{"issue":"46","key":"1262_CR67","doi-asserted-by":"publisher","first-page":"29113","DOI":"10.1074\/jbc.272.46.29113","volume":"272","author":"CM Allan","year":"1997","unstructured":"Allan CM, Taylor S, Taylor JM. Two hepatic enhancers, HCR.1 and HCR.2, coordinate the liver expression of the entire human apolipoprotein E\/C-I\/C-IV\/C-II gene cluster. J Biol Chem. 1997;272(46):29113\u20139.","journal-title":"J Biol Chem."},{"issue":"D1","key":"1262_CR68","doi-asserted-by":"publisher","first-page":"D506","DOI":"10.1093\/nar\/gky1049","volume":"47","author":"C UniProt","year":"2019","unstructured":"UniProt C. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47(D1):D506\u201315.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"1262_CR69","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/gim.2013.12","volume":"15","author":"F Silva","year":"2013","unstructured":"Silva F, Rodriguez-Revenga L, Madrigal I, Alvarez-Mora MI, Oliva R, Mila M. High apolipoprotein E4 allele frequency in FXTAS patients. Genet Med. 2013;15(8):639\u201342.","journal-title":"Genet Med"},{"issue":"5","key":"1262_CR70","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(5):1977\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1262_CR71","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12916-019-1299-4","volume":"17","author":"M Safieh","year":"2019","unstructured":"Safieh M, Korczyn AD, Michaelson DM. ApoE4: an emerging therapeutic target for Alzheimer\u2019s disease. BMC Med. 2019;17(1):64.","journal-title":"BMC Med"},{"key":"1262_CR72","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fgene.2014.00360","volume":"5","author":"AJ Renoux","year":"2014","unstructured":"Renoux AJ, Carducci NM, Ahmady AA, Todd PK. Fragile X mental retardation protein expression in Alzheimer\u2019s disease. Front Genet. 2014;5:360.","journal-title":"Front Genet"},{"issue":"5","key":"1262_CR73","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1601-183X.2012.00779.x","volume":"11","author":"F Tassone","year":"2012","unstructured":"Tassone F, Greco CM, Hunsaker MR, Seritan AL, Berman RF, Gane LW, et al. Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav. 2012;11(5):577\u201385.","journal-title":"Genes Brain Behav"},{"issue":"6","key":"1262_CR74","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/0891988716666379","volume":"29","author":"AL Seritan","year":"2016","unstructured":"Seritan AL, Kim K, Benjamin I, Seritan I, Hagerman RJ. Risk Factors for Cognitive Impairment in Fragile X-Associated Tremor\/Ataxia Syndrome. J Geriatr Psychiatry Neurol. 2016;29(6):328\u201337.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"12","key":"1262_CR75","doi-asserted-by":"publisher","first-page":"16676","DOI":"10.1096\/fj.202001880R","volume":"34","author":"M Zafarullah","year":"2020","unstructured":"Zafarullah M, Palczewski G, Rivera SM, Hessl DR, Tassone F. Metabolic profiling reveals dysregulated lipid metabolism and potential biomarkers associated with the development and progression of Fragile X-Associated Tremor\/Ataxia Syndrome (FXTAS). FASEB J. 2020;34(12):16676\u201392.","journal-title":"FASEB J"},{"issue":"6","key":"1262_CR76","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/hmg\/ddy410","volume":"28","author":"HE Kong","year":"2019","unstructured":"Kong HE, Lim J, Zhang F, Huang L, Gu Y, Nelson DL, et al. Metabolic pathways modulate the neuronal toxicity associated with fragile X-associated tremor\/ataxia syndrome. Hum Mol Genet. 2019;28(6):980\u201391.","journal-title":"Hum Mol Genet"},{"key":"1262_CR77","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.parkreldis.2020.11.026","volume":"82","author":"BD Dufour","year":"2020","unstructured":"Dufour BD, Amina S, Martinez-Cerdeno V. FXTAS presents with upregulation of the cytokines IL12 and TNFalpha. Parkinsonism Relat Disord. 2020;82:117\u201320.","journal-title":"Parkinsonism Relat Disord"},{"key":"1262_CR78","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3389\/fneur.2019.01179","volume":"10","author":"CD Wurster","year":"2019","unstructured":"Wurster CD, Koch JC, Cordts I, Dreyhaupt J, Otto M, Uzelac Z, et al. Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen. Front Neurol. 2019;10:1179.","journal-title":"Front Neurol"},{"issue":"2","key":"1262_CR79","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3233\/JAD-200168","volume":"75","author":"CS Musaeus","year":"2020","unstructured":"Musaeus CS, Gleerup HS, H\u00f8gh P, Waldemar G, Hasselbalch SG, Simonsen AH. Cerebrospinal Fluid\/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias. J Alzheimers Dis. 2020;75(2):429\u201336.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1262_CR80","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12987-020-0173-2","volume":"17","author":"M Castellazzi","year":"2020","unstructured":"Castellazzi M, Morotti A, Tamborino C, Alessi F, Pilotto S, Baldi E, et al. Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient. Fluids Barriers CNS. 2020;17(1):14.","journal-title":"Fluids Barriers CNS"}],"updated-by":[{"DOI":"10.1007\/s12311-021-01321-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000}}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-021-01262-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-021-01262-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-021-01262-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T19:31:57Z","timestamp":1675366317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-021-01262-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1262"],"URL":"https:\/\/doi.org\/10.1007\/s12311-021-01262-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12311-021-01321-z","asserted-by":"object"}]},"ISSN":["1473-4222","1473-4230"],"issn-type":[{"value":"1473-4222","type":"print"},{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"assertion":[{"value":"16 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2021","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12311-021-01321-z","URL":"https:\/\/doi.org\/10.1007\/s12311-021-01321-z","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}